Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in Laparoscopic Cholecystectomy
NCT05489900Phase 3Unknown
- Sponsor
- Federal University of Rio de Janeiro
- Start
- Apr 2022
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in Systemic Inflammatory Response Syndrome (SIRS), sponsored by Federal University of Rio de Janeiro. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on NCT05489900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05489900.